Processing of CFTR bearing the P574H mutation differs from wild-type and ΔF508-CFTR

Journal of Cell Science

Volumn 112, Issue 13, 1999, Pages 2091-2098

  Ostedgaard, Lynda S ^a   Zeiher, Bernhardt ^a   Welsh, Michael J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Cystic fibrosis; Hsp70; Protein biosynthesis

Indexed keywords

BREFELDIN A; HEAT SHOCK PROTEIN 70; MUTANT PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; TEMPERATURE SENSITIVITY;

ANIMALS; BREFELDIN A; COS CELLS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MUTAGENESIS, SITE-DIRECTED; POINT MUTATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SYNTHESIS INHIBITORS; SEQUENCE DELETION; TEMPERATURE;

ANIMALIA;

EID: 0032867811     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Anderson, R. G. W., Orci, L., Brown, M. S., Garcia-Segura, L. M. and Goldstein, J. L. (1983). Ultrastructural analysis of crystalloid endoplasmic reticulum in UT-1 cells and its disappearance in response to cholesterol. J. Cell Sci. 63, 1-20.
2. Bloom, G. S. and Brashear, T. A. (1989). A novel 58-kDa protein associates with the Golgi apparatus and microtubules. J. Biol. Chem. 264, 16083-16092.
3. Bradbury, N. A., Jilling, T., Berta, G., Sorscher, E. J., Bridges, R. J. and Kirk, K. L. (1992). Regulation of plasma membrane recycling by CFTR. Science 256, 530-532.
4. Bradbury, N. A., Cohn, J. A., Venglarik, C. J. and Bridges, R. J. (1994). Biochemical and biophysical identification of cystic fibrosis transmembrane conductance regulator chloride channels as components of endocytic clathrin-coated vesicles. J. Biol. Chem. 269, 8296-8302.
5. Brodsky, F. M. (1988). Living with clathrin: its role in intracellular membrane traffic. Science 242, 1396-1402.
6. - channel activity compensates for defective processing in a cystic fibrosis mutant corresponding to a mild form of the disease. EMBO J. 14, 2417-2423.
7. Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souza, D. W., White, G. A., O'Riordan, C. R. and Smith, A. E. (1990). Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63, 827-834.
8. Chin, D. J., Luskey, K. I., Anderson, R. G., Faust, J. R., Goldstein, J. L. and Brown, M. S. (1982). Appearance of crystalloid endoplasmic reticulum in compactin-resistant Chinese hamster cells with a 500-fold increase in 3-hydroxy-3-methylglutaryl-coenzyme A reductance. Proc. Nat. Acad. Sci. USA 79, 1185-1189.
9. Collins, F. S. (1992). Cystic fibrosis: molecular biology and therapeutic implications. Science 256, 774-779.
10. Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E. and Welsh, M. J. (1992a). Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358, 761-764.
11. Denning, G. M., Ostedgaard, L. S., Cheng, S. H., Smith, A. E. and Welsh, M. J. (1992b). Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia. J. Clin. Invest. 89, 339-349.
12. Duden, R., Griffiths, G., Frank, R., Argos, P. and Kreis, T. E. (1991). Beta-COP, a 110 kd protein associated with non-clathrin-coated vesicles and the Golgi complex, shows homology to beta-adaptin. Cell 64, 649-665.
13. Elroy-Stein, O., Fuerst, T. R. and Moss, B. (1989). Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5′ sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Proc. Nat. Acad. Sci. USA 86, 6126-6130.
14. Gan, K. H., Veeze, H. J., van den Ouweland, A. M., Halley, D. J., Scheffer, H., van der Hout, A., Overbeek, S. E., de Jongste, J. C., Bakker, W. and Heijerman, H. G. (1995). A cystic fibrosis mutation associated with mild lung disease. New Engl. J. Med. 333, 95-99.
15. Gregory, R. J., Cheng, S. H., Rich, D. P., Marshall, J., Paul, S., Hehir, K., Ostedgaard, L., Klinger, K. W., Welsh, M. J. and Smith, A. E. (1990). Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature 347, 382-386.
16. Hartl, F. U. (1996). Molecular chaperones in cellular protein folding. Nature 381, 571-580.
17. Hobman, T. C., Woodward, L. and Farquhar, M. G. (1992). The rubella virus El glycoprotein is arrested in a novel post-ER, pre-golgi compartment. J. Cell Biol. 118, 795-811.
18. Ishihara, N., Yamashina, S., Sakaguchi, M., Mihara, K. and Omura, T. (1995). Malfolded cytochrome P-450(M1) localized in unusual membrane structures of the endoplasmic reticulum in cultured animal cells. J. Biochem. (Tokyo) 118, 397-404.
19. Kaetzel, C. S., Rao, C. K. and Lamm, M. E. (1987). Protein disulphilde-isomerase from human placenta and rat liver. Biochem. J. 241, 39-47.
20. Kerem, B. S., Zielenski, J., Markiewicz, D., Bozon, D., Gazit, E., Yahav, J., Kennedy, D., Riordan, J. R., Collins, F. S., Rommens, J. M. et al. (1990a). Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc. Nat. Acad. Sci. USA 87, 8447-8451.
21. Kerem, E., Corey, M., Kerem, B. S., Rommens, J., Markiewicz, D., Levison, H., Tsui, L. C. and Durie, P. (1990b). The relation between genotype and phenotype in cystic fibrosis-analysis of the most common mutation (delta F508). New Eng. J. Med. 323, 1517-1522.
22. Kristidis, P., Bozon, D., Corey, M., Markiewicz, D., Rommens, J., Tsui, L.-C. and Durie, P. (1992). Genetic determination of exocrine pancreatic function in cystic fibrosis. Am. J. Hum. Genet. 50, 1178-1184.
23. Kunkel, T. A. (1985). Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Nat. Acad. Sci. USA 82, 488-492.
24. Lehrich, R. W., Aller, S. G., Webster, P., Marino, C. R. and Forrest, J. N. Jr. (1998). Vasoactive intestinal peptide, forskolin and genistein increase apical CFTR trafficking in the rectal gland of the spiny dogfish, Squalus acanthias. J. Clin. Invest. 101, 737-745.
25. Lukacs, G. L., Chang, X.-B., Bear, C., Kartner, N., Mohamed, A., Riordan, J. R. and Grinstein, S. (1993). The ΔF508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. J. Biol. Chem. 268, 21592-21598.
26. Lukacs, G. L., Mohamed, A., Kartner, N., Chang, X. B., Riordan, J. R. and Grinstein, S. (1994). Conformational maturation of CFTR but not its mutant counterpart (ΔF508) occurs in the endoplasmic reticulum and requires ATP. EMBO J. 13, 6076-6086.
27. Misumi, Y., Miki, K., Takatsuki, A., Tamura, G. and Ikehara, Y. (1986). Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J. Biol. Chem. 261, 11398-11403.
28. Ostedgaard, L. S. and Welsh, M. J. (1992). Partial purification of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 267, 26142-26149.
29. Parrish, M. L., Sengstag, C., Rine, J. D. and Wright, R. L. (1995). Identification of the sequences in HMG-CoA reductase required for karmellae assembly. Mol. Biol. Cell 6, 1535-1547.
30. Pind, S., Riordan, J. R. and Williams, D. B. (1994). Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 269, 12784-12788.
31. Qu, B.-H. and Thomas, P. J. (1996). Alteration of the cystic fibrosis transmembrane conductance regulator folding pathway. J. Biol. Chem. 271, 7261-7264.
32. Qu, B.-H., Strickland, E. H. and Thomas, P. J. (1997). Localization and suppression of a kinetic defect in cystic fibrosis transmembrane conductance regulator folding. J. Biol. Chem. 272, 15739-15744.
33. Raposo, G., van Santen, H. M., Leijendekker, R., Geuze, H. J. and Ploegh, H. L. (1995). Misfolded major histocompatibility complex class I molecules accumulate in an expanded ER-Golgi intermediate compartment. J. Cell Biol. 131, 1403-1419.
34. Rich, D. P., Anderson, M. P., Gregory, R. J., Cheng, S. H., Paul, S., Jefferson, D. M., McCann, J. D., Klinger, K. W., Smith, A. E. and Welsh, M. J. (1990). Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 347, 358-363.
35. Riordan, J. R. (1993). The cystic fibrosis transmembrane conductance regulator. Annu. Rev. Physiol. 55, 609-630.
36. Sato, S., Ward, C. L., Krouse, M. E., Wine, J. J. and Kopito, R. R. (1996). Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J. Biol. Chem. 271, 635-638.
37. Sheppard, D. N., Ostedgaard, L. S., Winter, M. C. and Welsh, M. J. (1995). Mechanism of dysfunction of two nucleotide binding domain mutations in cystic fibrosis transmembrane conductance regulator that are associated with pancreatic sufficiency. EMBO J. 14, 876-883.
38. Tsui, L. C. (1995). The cystic fibrosis transmembrane conductance regulator gene. Am. J. Respir. Crit. Care Med. 151, S47-S53.
39. van den Hoff, M. J., Moorman, A. F. and Lamers, W. H. (1992). Electroporation in 'intracellular' buffer increases cell survival. Nucl. Acids Res. 20, 2902.
40. Veeze, H. J., Halley, D. J. J., Bijman, J., de Jongste, J. C., de Jonge, H. R. and Sinaasappel, M. (1994). Determinants of mild clinical symptoms in cystic fibrosis patients. Residual chloride secretion measured in rectal biopsies in relation to the genotype. J. Clin. Invest. 93, 461-466.
41. Ward, C. L. and Kopito, R. R. (1994). Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. J. Biol. Chem. 269, 25710-25718.
42. Welsh, M. J., Tsui, L.-C., Boat, T. F. and Beaudet, A. L. (1995). Cystic Fibrosis. In The Metabolic and Molecular Basis of Inherited Disease (ed. C. R. Scriver, A. L. Beaudet, W. S. Sly and D. Valle), pp. 3799-3876. McGraw-Hill, Inc., New York.
43. Welsh, M. J. and Ostedgaard, L. S. (1998). Cystic fibrosis problem probed by proteolysis. Nature Struct. Biol. 5, 167-169.
44. Wright, R., Basson, M., D'Ari, L. and Rine, J. (1988). Increased amounts of HMG-CoA reductase induce 'karmellae': a proliferation of stacked membrane pairs surrounding the yeast nucleus. J. Cell Biol. 107, 101-114.
45. Yamamoto, A., Masaki, R. and Tashiro, Y. (1996). Formation of crystalloid endoplasmic reticulum in COS cells upon overexpression of microsomal aldehyde dehydrogenase by cDNA transfection. J. Cell Sci. 109, 1727-1738.
46. Yang, Y., Janich, S., Cohn, J. A. and Wilson, J. M. (1993). The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment. Proc. Nat. Acad. Sci. USA 90, 9480-9484.
47. Zhang, F., Kartner, N. and Lukacs, G. L. (1998). Limited proteolysis as a probe for arrested conformational maturation of ΔF508 CFTR. Nature Struct. Biol. 5, 180-183.